Matthew W. Towse, SVP and Chief Financial Office at NxStage Medical, Inc. (NXTM), sold 8,591 shares at $19.50 ($168K) on 2015-11-04, disclosed to the SEC on 2015-11-04.
Scheduled sale ($168k) by SVP and Chief Financial Office under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| NXTM | SELL | 2017-08-23 | $126K | — | Filing → |
| NXTM | SELL | 2017-07-21 | $104K | — | Filing → |
| NXTM | SELL | 2017-06-21 | $100K | — | Filing → |